Hydroxylation at C-3′ of doxorubicin alters the selected phenotype of cellular drug resistance

Hydroxylation at C-3′ of doxorubicin alters the selected phenotype of cellular drug resistance Nitric Oxide Donor Doxorubicins Accumulate into Doxorubicin-Resistant Human Colon Cancer Cells Inducing Cytotoxicity The antiprogestatin drug RU 486 potentiates doxorubicin cytotoxicity in multidrug resistant cells through inhibition of P‐glycoprotein function N-(2-Hydroxyethyl)doxorubicin from hydrolysis of 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin Up‐Regulation of P‐Glycoprotein Expression in Rat Liver Cells by Acute Doxorubicin Treatment Doxorubicin-antioxidant co-drugs Discovery of a Daunorubicin Analogue That Exhibits Potent Antitumor Activity and Overcomes P-gp-Mediated Drug Resistance Overcoming doxorubicin-resistance in the NCI/ADR-RES model cancer cell line by novel anthracene-9,10-dione derivatives Doxorubicin analogs incorporating chemically reactive substituents Overcoming multidrug resistance by targeting mitochondria with NO-donating doxorubicins